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Highly active antiretroviral therapy (HAART) has improved prognosis for people living with 
HIV (PLWH) and dramatically reduced the incidence of AIDS. However, even when viral 
load is controlled, PLWH develop psychiatric and neurological disorders more frequently 
than those living without HIV. Adolescents with HIV are particularly susceptible to the 
development of psychiatric illnesses and neurocognitive impairments. While both psy-
chiatric and neurocognitive disorders have been found to be exacerbated by stress, the 
extent to which chronic stress and HIV-1 viral proteins interact to impact behavior and 
relevant neuroinflammatory processes is unknown. Determination of the individual contri-
butions of stress and HIV to neuropsychiatric disorders is heavily confounded in humans. 
In order to isolate the influence of HIV-1 proteins and chronic stress on behavior and 
neuroinflammation, we employed the HIV-1 transgenic (Tg) rat model, which expresses 
HIV-1 proteins with a gag and pol deletion, allowing for viral protein expression without 
viral replication. This Tg line has been characterized as a model of HAART-controlled 
HIV-1 infection due to the lack of viral replication but continued presence of HIV-1 
proteins. We exposed male and female adolescent HIV-1 Tg rats to a mixed-modality 
chronic stress paradigm consisting of isolation, social defeat and restraint, and assessed 
behavior, cerebral vascularization, and neuroinflammatory endpoints. Stress, sex, and 
presence of the HIV-1 transgene impacted weight gain in adolescent rats. Female HIV-1 
Tg rats showed decreases in central tendency during the light cycle in the open field 
regardless of stress exposure. Both male and female HIV-1 Tg rats exhibited decreased 
investigative behavior in the novel object recognition task, but no memory impairments. 
Adolescent stress had no effect on the tested behaviors. Microglia in female HIV-1 Tg 
rats exhibited a hyper-ramified structure, and gene expression of complement factor B 
was increased in the hippocampus. In addition, adolescent stress exposure increased 
microglial branching and junctions in female wild-type rats without causing any additional 
increase in HIV-1 rats. These data suggest that the presence of HIV-1 proteins during 
development leads to alterations in behavioral and neuroinflammatory endpoints that are 
not further impacted by concurrent chronic adolescent stress.
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inTrODUcTiOn
Following the advent of highly active antiretroviral therapy 
(HAART) in the treatment of HIV-1 infection, the life expectancy 
for people living with HIV (PLWH) has greatly increased (1). 
However, with increasing life expectancy among PLWH, com-
plications not traditionally associated with HIV infection have 
emerged (1). These comorbidities include increased incidence of 
affective disorders, HIV-1-associated neurocognitive disorders 
(HAND), and non-AIDS-associated dementia and can occur even 
in individuals with HAART-controlled viral load. In fact, as many 
as 52% of PLWH experience some form of neuropsychological 
impairment (2). PLWH are at a greater risk of developing a mood 
disorder (3), and individuals with HAND are less likely to adhere 
to life-saving treatment regimens (4), increasing the risk of death 
(5). As many as 60% of the adolescents living with HIV develop 
psychiatric illnesses (6, 7) or neurocognitive impairments (8). 
These adolescents are at high risk of unsafe behaviors (9), but 
the mechanisms underlying this sensitivity to neuropsychiatric 
disease are unknown. Furthermore, the risks may be particularly 
high for HIV-infected females, given the established increased 
risk for affective disorders in women over men even in the 
absence of HIV (10, 11).
While stigma or distress associated with HIV-positive status 
has been suggested to contribute to neurocognitive impairment 
and the increased prevalence of mood disorders among PLWH, 
recent studies suggest that these behavioral pathologies are also 
mediated by biological mechanisms that extend beyond the direct 
impact of psychosocial stress associated with being HIV-positive 
(12–16). These studies have examined HIV-associated altera-
tions in behavior and their underlying biological mechanisms, 
many of which involve neuroinflammatory processes. However, 
due to the difficulty of disentangling the impact of HIV-1 viral 
proteins and psychosocial stress in PLWH, the potential interac-
tion between chronic stress and HIV-1 viral proteins remains 
incompletely understood. Using the HIV-1 transgenic (Tg) rat 
model, we sought to examine the contributions of developmental 
exposure to HIV-1 proteins and chronic adolescent stress in 
order to better understand the extent to which HIV and stress 
interact in adolescents with HIV.
The HIV-1 Tg rat expresses all but two of the genes contained 
in the HIV-1 virus, which allows expression of functional viral 
proteins without active viral replication (17). This non-replicating 
HIV-1 Tg line in the rat has been characterized as a useful tool to 
model comorbidities experienced by PLWH receiving HAART 
(18) as well as a model for other childhood HIV-1-associated 
disorders (19).
Here, we used the HIV-1 Tg rat to address the hypothesis 
that chronic adolescent stress exacerbates behavioral and neu-
roinflammatory impairments in HIV-1 Tg rats compared to 
wild-type (WT) controls in a sex-specific manner. We focused 
on inflammatory endpoints due to their capacity to modulate 
affective and cognitive behavior as well as the profound immune 
alterations seen in HIV-1 infection. We assessed microglial 
morphology in females as well as gene expression of comple-
ment factor B and lipocalin-2, two inflammatory proteins that 
may also be involved in neuronal structure and the impairments 
observed in PLWH, in non-stressed female rats. Collectively, 
the data presented suggest that females are more susceptible 
to the behavioral effects of HIV-1 protein expression during 
development than males and that HIV-1 proteins mirror, but 
do not interact with, the neuroinflammatory impact of chronic 
adolescent stress in females.
MaTerials anD MeThODs
animals
Wild-type and HIV-1 Tg male and female rats were bred on-site 
from Tg male breeders and WT female Fisher 344/NHsd dams 
purchased from Harlan Laboratories (Indianapolis, IN, USA). 
The HIV-1 Tg rat, originally described by Reid et al. (17), was 
derived from the Fisher 344/NHsd Sprague–Dawley line. HIV-1 
Tg rats show clinical manifestations and pathology resembling 
HIV, including respiratory problems, neurological changes, 
cataracts, nephropathy, muscle atrophy, and altered affective-
type behavior (15, 17, 19, 20). The studies presented here were 
completed by postnatal day (PND) 55 and thus occurred prior 
to the onset of previously documented pathology. Offspring were 
group-housed with siblings (2–3 rats per cage) after weaning. 
Male and female rats were used for all behavioral analyses, 
while female rats were used for histological and gene expres-
sion assessments. Animals were kept in an AAALAC-approved 
temperature- and humidity-controlled vivarium and maintained 
on a reverse 14:10 light:dark cycle. Food and water were available 
ad libitum. For these studies, litters were split among all groups 
such that no more than two pups from a litter were in any one 
group. This measure was taken in order to avoid litter effects. 
Chronic mixed-modality adolescent stress took place from 
PND37 to PND48; behavioral assessments were performed from 
PND49 to PND53, and rats were euthanized between PND54 
and PND55. All experiments were performed in accordance with 
the Institutional Animal Care and Use Committee of Emory 
University and the National Institutes of Health Guide for the 
Care and Use of Laboratory Animals.
chronic Mixed-Modality stress
A subset of each cohort was submitted to chronic mixed-
modality adolescent stress (WT-male-control n = 8, WT-male-
stressed n = 9, WT-female-control n = 11, WT-female-stressed 
n  =  10, Tg-male-control n  =  11, Tg-male-stressed n  =  11, 
Tg-female-control n = 10, and Tg-female-stressed n = 9). This 
mixed-modality stress paradigm has been previously described 
and shown to elicit both short-term and lasting behavioral and 
physiological changes in Wistar rats (21–24). Consistent with 
the previously established paradigm, animals receiving stress 
were individually housed at PND36 and randomly exposed to 
interspersed days of social defeat and restraint stress for 12 days 
(PND37–PND48). Stressed animals were individually housed 
throughout the duration of behavioral testing. Non-stressed 
animals remained pair-housed throughout the entire study and 
encountered daily handling and cage movement to control for the 
stress paradigm. Rats were weighed on isolation day and twice 
throughout stress.
TaBle 1 | sample sizes for each of the behavioral tests (open-field 
and novel object recognition task), animal weight data, and molecular 
analyses are detailed.
Test F WT  
ns
F Tg  
ns
M WT  
ns
M Tg  
ns
F WT  
s
F Tg  
s
M WT  
s
M Tg 
s
Novel object 9 7 8 9 10 4 8 11
Open field 11 10 7 11 10 9 8 9
Body weight 
over stress
11 10 8 11 10 9 8 11
Terminal 
weight
11 10 8 9 9 9 6 11
Microglial 
analysis
3 3 N/A N/A 3 3 N/A N/A
Lcn2 gene 
expression
7 10 N/A N/A N/A N/A N/A N/A
Cfb gene 
expression
10 11 N/A N/A N/A N/A N/A N/A
Animals used in behavior analysis were included in weight analysis. M, male; F, female; 
NS, no stress; S, stress; WT, wild type; Tg, transgenic.
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The 6 days of social defeat stress were performed during the 
light phase of the light:dark cycle and took place in the home 
cage of a mature, territorial, Long–Evans rat. All experimental 
animals were paired with a same-sex resident Long–Evans rat, 
and female resident Long–Evans rats were ovariectomized to 
control for estrous cycle-dependent variations in aggressive 
behavior. Each experimental animal was placed in the home 
cage of the resident and separated by a barrier permeable to 
sound and scent; after 2  min, the barrier was lifted. After the 
experimental animal was aggressed by the resident up to five 
times on the first day, three times on the second day, and once 
each day thereafter, or after 5  min of interaction, the barrier 
was replaced. This separation continued for 25 min, after which 
point the experimental animal was returned to its home cage. 
Pairings were randomly assigned daily to prevent stabilization 
of a dominance hierarchy.
For the 6  days of restraint stress, animals were placed in a 
clear acrylic rat restraint (Braintree Scientific, Inc., Braintree, 
MA, USA) for 60  min during the light phase. These restraints 
prevented head-to-tail turns but did not compress the rat.
Behavioral Testing
Behavioral testing took place from PND49 to PND53, after the 
completion of the stress paradigm, and consisted of open-field 
testing and novel object testing. The behavioral testing was com-
pleted in six cohorts across a 4-month span of time with all groups 
represented equally in each cohort. The length of testing for any 
one cohort was 5 days. Sample sizes are detailed in Table 1.
Open-field Testing
Measurement of locomotor activity and spatial preference during 
the open-field test can be used as an assessment of both physi-
ological capacity as well as anxiety-like behavior (25). Animals 
were assessed in the open field during the light phase under white 
light (between 8:00 and 11:00 a.m.) on PND49 and during the 
dark phase under red lighting (between 3:00 and 6:00 p.m.) on 
PND50. For both tests, each rat was placed into a 90 cm × 90 cm 
box and allowed to explore freely for 10 min, after which time 
the rat was placed back in its home cage, and the open-field arena 
was cleaned thoroughly with 70% ethanol. One rat was tested at a 
time. All behaviors in both the light and dark phase testing were 
recorded by a video camera that was connected to an automated 
behavior analysis system and analyzed by research assistant blind 
to experimental group (CleverSys, Inc., Reston, VA, USA). Four 
animals (Tg-male-stressed n = 2, WT-male-control n = 1, and 
WT-male-stressed n = 1) were excluded from open-field analysis 
due to a procedural error.
Novel Object Testing
The novel object test is used to assess object recognition memory, 
a task that is dependent on hippocampal function (26). Training 
and testing occurred during the light phase between 8:00 a.m. 
and 12:00 p.m., and two animals were tested simultaneously, 
individually in separate chambers. The chamber used for the 
open-field test was subdivided into two 90 cm × 45 cm arenas. On 
PND51, rats were habituated to the smaller arena with a 10-min 
exploration period. On PND52 and 53, rats were exposed to the 
no-delay and the hour-delay tasks in a counterbalanced order. 
In the no-delay task, the rat was placed into the arena with two 
identical objects (“familiar objects”) and allowed to explore for 
15 min. After this period, the rat was briefly returned to its home 
cage; the objects and arena were quickly cleaned with 70% ethanol, 
and one of the objects was replaced with a novel object. The rat 
was returned to the arena and allowed to explore the objects for 
5 min. All behaviors during this period were recorded by a video 
camera that was connected to an automated behavior analysis 
system and analyzed by a research assistant blind to experimental 
group (CleverSys, Inc., Reston, VA, USA). The hour-delay task 
was identical to the no-delay task but used different novel and 
familiar objects, and the rat was returned to its home cage for 
a 1-h delay before undergoing the 5-min recorded encounter. 
Several rats were excluded from novel object behavioral analysis 
due to a procedural error (WT-female-control n = 2, WT-male-
stressed n = 1, Tg-male-control n = 2, Tg-female-control n = 2, 
and Tg-female-stressed n = 5). Difference in time spent sniffing 
novel vs. familiar object was calculated by taking the absolute 
value of the difference in time spent sniffing the novel and famil-
iar objects. One animal (Tg-female-control) was identified as an 
outlier via Grubbs’ test (α = 0.05) and was removed from novel 
object analysis.
Tissue collection
On PND54–55, all animals used for behavioral tests and stereology 
were euthanized with Euthasol® (a combination of pentobarbital 
sodium and phenytoin sodium), perfused for 2 min with ice cold 
saline, and then perfused with 4% paraformaldehyde for 10 min. 
Estrous cycle was not monitored in females. Brains were removed 
and postfixed in 4% paraformaldehyde and cryoprotected in 30% 
sucrose for 24 h before freezing. Female WT (n = 11) and HIV-1 
Tg (n = 11) non-stressed animals that did not undergo behavioral 
testing were euthanized via rapid decapitation for quantitative 
real-time polymerase chain reaction (qPCR) analysis. Brains 
were flash frozen on dry-ice and stored at −80°C until later 
analysis. In addition, adrenal glands, uteri, and testes were col-
lected, weighed, and normalized to terminal weights. Percentage 
4Rowson et al. Neuroinflammation and Behavior in HIV-1 Transgenic Rats
Frontiers in Psychiatry | www.frontiersin.org June 2016 | Volume 7 | Article 102
weight change over stress was calculated by dividing the differ-
ence between day 10 stress weight and isolation weight by the 
isolation weight. Normalized adrenal and reproductive weights 
were calculated by dividing each rat’s adrenal or reproductive 
weight (milligrams) by its terminal body weight (grams). All 
weight analyses were performed with animals that underwent 
behavioral testing.
immunohistochemistry and stereology
Brains from female rats were sectioned at 40 or 50  μm on a 
cryostat.
IBA-1 Immunohistochemistry
Sections from female WT-control, WT-stress, Tg-control, 
and Tg-stress (n =  3 per group) rats encompassing the entire 
rostro–caudal axis of the brain were stained for ionized calcium-
binding adaptor molecule-1 (IBA-1) [four sections per animal, 
section sampling fraction (ssf) =  1/12]. After washing in TBS, 
sections were blocked in a 10 μg/ml avidin solution for 1  h at 
4°C. Sections were washed again and then incubated in rabbit 
IBA-1 (1:1000, 019-19741, WAKO, Richmond, VA, USA) in a 
50 μg/ml biotin solution overnight at 4°C. Sections were then 
washed and incubated in biotinylated goat anti-rabbit IgG (BA-
1000, Vector Labs, Burlingame, CA, USA) for 1 h at 4°C before 
washing and incubating with the Vectastain Elite ABC kit (Vector 
Labs, Burlingame, CA, USA). The stain was then visualized with 
diaminobenzidine (SigmaFast 3,3′-diaminobenzidine tablets, 
Sigma–Aldrich, St. Louis, MO, USA), and sections were counter-
stained in cresyl violet. The optical fractionator probe was used 
to estimate the population of microglia in a single hemisphere of 
the hippocampus.
Microglial Morphology Analysis
Right hippocampal regions from four sections (three from one 
animal due to tissue integrity) from each animal were stitched 
together at 40× magnification (StereoInvestigator). Thirty cells 
were chosen at random per section, converted to 8-bit, adjusted 
for brightness, and cleaned with a Gaussian filter. Images were 
then converted to binary and skeletonized in ImageJ (National 
Institute of Health, version 1.49). The AnalyzeSkeleton plug-in 
was used to assess the number of junctions and average branch 
length for each microglia. Microglial properties (number of junc-
tions, number of branches, maximum and average branch length) 
were averaged for each animal.
Cerebrovascular Immunohistochemistry
Sections from female rats were incubated with 1% H2O2 for 20 min 
at 4°C followed by blocking with normal goat serum (NGS) 
(3%) (Vector Labs, Burlingame, CA, USA), Triton X-100 (0.5%) 
(Sigma–Aldrich, St. Louis, MO, USA), and phosphate-buffered 
saline (PBS). Sections were then incubated with primary antibody 
mouse anti-rat endothelial cell antigen-1 [RECA-1 (0.5%) (Bio-
Rad Labs, Berkeley, CA, USA)] overnight at 4°C. The following 
day, sections were incubated with biotinylated anti-mouse IgG 
secondary antibody (0.5%) (Vector Labs, Burlingame, CA, USA). 
Sections were then incubated with streptavidin–peroxidase–HRP. 
The stain was visualized with diaminobenzidine. Sections were 
mounted on slides, dried overnight, and coverslipped with 
Permount (Fisher Scientific, Pittsburgh, PA, USA).
Blood Vessel Length and Density
To minimize bias, stereology was conducted by a single 
experimenter blind to experimental conditions. To determine 
the location of the prefrontal cortex (PFC) (WT n = 3, Tg n = 5), 
amygdala (WT n = 5, Tg n = 6), and hippocampus (WT n = 5, 
Tg n =  6) in each section, a rat atlas (27) was used as a guide 
to trace contours under 2× bright-field illumination. Three sec-
tions were used per animal for analysis. After tracing contours, 
sections were sampled under a 60× oil immersion objective. 
Estimates were taken using the Stereo Investigator system with 
the Spaceballs probe (MicroBrightField, Inc., Colchester, VT, 
USA). The following parameters were used in the Spaceballs 
probe for 40 and 50 μm sections analyzing the PFC: grid size 
X =  230 μm, grid size Y =  315 μm, guard zone space =  fixed 
distance, Spaceball radius = 12 μm, and use hemisphere = true. 
Additionally, the following parameters were used for sections 
analyzing the hippocampus and amygdala: grid size X = 275 μm, 
grid size Y = 360 μm, guard zone space = fixed distance, Spaceball 
radius = 12 μm, and use hemisphere =  true. These parameters 
resulted in a coefficient of error of ≤0.1.
Quantitative real-Time Polymerase 
chain reaction
The PFC and hippocampus were dissected from female WT 
(n =  11) and HIV-1 Tg (n =  11) rats, and RNA was extracted 
with the TRIzol method (Invitrogen) using the RNeasy Mini Kit 
(Qiagen). RNA was reverse-transcribed using the High Capacity 
cDNA Reverse Transcription Kit (Applied Biosystems). cDNA 
was standardized using a Pico Green Assay (Invitrogen). TaqMan 
Gene Expression Mastermix and TaqMan Gene Expression Assays 
for Hprt1 (Rn01527840_m1) and Cfb (Rn01526084_g1) were 
used. qPCR was performed on the Applied Biosystems 7900HT 
Sequence Detection System. Fold change in gene expression was 
calculated according to the 2−ΔΔCt method using the Hprt1 house-
keeping gene. The targets were run in triplicate, and the cutoff for 
coefficient of variance (CV) was 4%. One WT animal was excluded 
from Cfb analysis because its CV value exceeded the 4% cutoff.
Gene expression of Lcn2 (female WT n = 7, Tg n = 10) was 
assessed using primers from Integrated DNA Technologies (San 
Diego, CA, USA). Forward: GATTCGTCAGCTTTGCCAAGT 
and reverse: CATTGGTCGGTGGGAACAG. Absolute Blue 
qPCR SYBR Green ROX Mix (Thermo Scientific, Wilmington, 
DE, USA) was used to perform qPCR. Hippocampal gene expres-
sion of Lcn2 was normalized to the geometric mean of Hprt and 
B2m, whereas PFC expression of Lcn2 was normalized to the 
geometric mean of B-actin, Hprt1, B2m, and Ldha.
statistical analysis
Three-way analysis of variance (ANOVA) in R (version 3.2.1) 
was used to assess statistical significance in behavioral tests, 
percentage weight gain, and normalized adrenal measures. The 
analysis factors in three-way analysis of percentage weight gain 
FigUre 1 | chronic adolescent stress reduced weight gain from PnD36 to PnD46. Females and HIV-1 Tg rats also gained less weight during 
stress (a). Terminal adrenal weight was normalized to terminal body weight, and normalized adrenal weight was increased in HIV-1 Tg rats and in females (B). 
Normalized reproductive weight was decreased in males exposed to adolescent stress but increased with HIV-1 transgene (c). Normalized reproductive weight in 
females was unchanged by HIV-1 transgene or stress (D). Data are presented as mean ± SEM. # denotes a main effect of HIV-1 Tg genotype, *Denotes a main 
effect of stress, and $ denotes a main effect of sex. α = 0.05.
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and normalized adrenal weight were all between-subjects and 
included sex, stress (control, adolescent stress), and genotype 
(WT, HIV-1 Tg). The analysis factors in three-way analyses of 
behavior were the between-subjects factors of stress (control, 
adolescent stress) and genotype (WT, HIV-1 Tg) with the 
repeated factor of time (light and dark in the open-field test or 
no delay and hour delay in the novel object test). Because of the 
added factor of time, sexes were assessed separately. If no main 
effect was present, the non-significant factor was removed from 
post  hoc assessment leading to a t-test assessment. Two-way 
ANOVAs in GraphPad Prism (version 6) were used to assess 
group differences for reproductive weight, microglial population, 
and microglial morphology. The factors in two-way analyses 
were stress and genotype. Student’s t-test was performed to assess 
statistical significance of number of microglial branches and 
number of microglial junctions between the WT control group 
and the Tg control group. A student’s t-test was used to assess 
statistical significance for gene expression data. Each gene and 
region was compared to its WT control. All tests were performed 
with α = 0.05, and all significant main effects and interactions are 
reported in the section “Results.”
resUlTs
Both chronic adolescent stress and hiV-1 
Proteins reduced Weight gain
Exposure to chronic adolescent stress reduced weight gain in 
stressed animals [F(1,70) = 70.91, p < 0.01] (Figure 1A). Females 
[F(1,70) = 79.21, p < 0.01] and HIV-1 Tg rats [F(1,70) = 5.80, p = 0.02] 
also gained less weight during stress as compared to males and 
WT rats. However, terminal weight was unchanged by stress 
[F(1,65) = 1.72, p > 0.05]. HIV-1 Tg rats weighed less at collection 
than WT rats [F(1,65) =  150.88, p =  0.01]. Female rats weighed 
less than males [F(1,65) = 199.81, p < 0.01] (Table 2). Normalized 
adrenal weight was higher in females [F(1,65) = 44.60, p < 0.01] and 
HIV-1 Tg rats [F(1,65) = 6.53, p = 0.01] (Figure 1B). Normalized 
TaBle 3 | F-statistics and p-values for all main effects and interactions are shown for weight analysis using a three-way anOVa, between factors (sex, 
hiV-1 genotype, time), or a two-way anOVa, between factors (hiV-1 genotype and stress).
sex hiV-1  
genotype
stress sex × hiV-1 
genotype
sex × stress stress × hiV-1  
genotype
sex × stress × 
hiV-1 genotype
Weight over stress (1A) *F(1,70) = 79.2, 
p < 0.01
*F(1,70) = 5.80, 
p = 0.02
*F(1,70) = 70.91, 
p < 0.01
F(1,70) = 2.11, 
p > 0.05
F(1,70) = 1.54, 
p > 0.05
F(1,70) = 0.16, 
p > 0.05
F(1,70) = 0.09, 
p > 0.05
Adrenal weight (1B) *F(1,65) = 44.60, 
p < 0.01
*F(1,65) = 6.53, 
p = 0.01
F(1,65) = 3.66, 
p > 0.05
F(1,65) = 0.02, 
p > 0.05
F(1,65) = 0.04, 
p > 0.05
F(1,65) = 1.66, 
p > 0.05
F(1,65) = 0.03, 
p > 0.05
Male reproductive 
weight (1C)
*F(1,31) = 16.09, 
p < 0.01
*F(1,31) = 6.87, 
p = 0.01
F(1,31) = 0.25, 
p > 0.05
Female reproductive 
weight (1D)
F(1,34) = 0.12, 
p > 0.05
F(1,34) = 2.05, 
p > 0.05
F(1,34) = 0.35, 
p > 0.05
Terminal weight 
(Table 2)
*F(1,65) = 199.8, 
p < 0.01
*F(1,65) = 150.9, 
p < 0.01
F(1,65) = 1.72, 
p > 0.05
F(1,65) = 2.41, 
p > 0.05
F(1,65) = 0.27, 
p > 0.05
F(1,65) = 1.22, 
p > 0.05
F(1,65) = 0.93, 
p > 0.05
*Indicates a significant main effect or interaction. Blank boxes indicate an absence of a particular factor from analysis. The figure or table number is included in parentheses following 
the description of each metric. α = 0.05.
TaBle 2 | Terminal weight (in grams) of rats that were exposed to 
chronic adolescent stress and behavioral testing.
Wild type hiV-1 transgenic
no stress stress no stress stress
Male 176.0 ± 4.56 g 168.0 ± 7.32 g 135.7 ± 4.59 gb 138.5 ± 2.81 gb
Female 135.2 ± 2.34 ga 129.9 ± 3.12 ga 107.3 ± 1.56 ga,b 103.1 ± 3.04 ga,b
Mean ± SEM are shown. HIV-1 Tg rats weighed less than WT rats [F(1,65) = 150.88, 
p < 0.01]. Females weighed less than males [F(1,65) = 199.81, p < 0.01].
aDenotes a main effect of sex.
bdenotes a main effect of HIV-1 genotype.
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reproductive weight was analyzed separately between the sexes 
due to the distinct differences in sex organs. Stress [F(1,31) = 6.87, 
p = 0.01] and HIV-1 transgene [F(1,31) = 16.09, p < 0.01] increased 
male reproductive weight (Figure 1C). Neither stress [F(1,34) = 2.05, 
p > 0.05] nor HIV-1 genotype [F(1,34) = 0.12, p > 0.05] impacted 
normalized reproductive weight in females (Figure 1D). Details 
of statistical analyses are detailed in Table 3.
Female hiV-1 Tg rats had reduced 
central Tendency in the Open-field Maze
As expected for a nocturnal species, male [F(1,31)  =  56.86, 
p < 0.01] and female [F(1,36) = 52.55, p < 0.01] rats, regardless 
of stress exposure or genotype, traveled greater distance in the 
open-field maze during the dark cycle than during the light 
cycle. Stress did not independently impact locomotor activity 
[F(1,36) = 1.78, p > 0.05] or percentage time in center [F(1,36) = 0.38, 
p > 0.05] for female rats of either genotype. Post hoc assessment 
demonstrated that female HIV-1 Tg rats exhibited decreased 
locomotor activity compared to female WT rats in the light 
cycle (t38 = 3.62, p < 0.001) (Figure 2A) and that female HIV-1 
rats spent a decreased time in the center of the open-field maze 
compared to female WT rats during the light cycle [t(1,38) = 2.35, 
p = 0.024] (Figure 2B). Male HIV-1 rats also exhibited decreased 
locomotor activity compared to male WT rats in the light cycle 
(t33 = 2.93, p < 0.01). Female [F(1,36) = 29.35, p < 0.001] and male 
[F(1,31) = 24.46, p < 0.001] rats also spent an increased percentage 
of time in the center of the open-field maze during the dark cycle, 
as compared to percentage time in center during the light cycle 
(Figures  2B,D). HIV-1 transgene and time of day interacted 
in males [F(1,31) =  13.23, p <  0.001] and females [F(1,36) =  8.68, 
p < 0.01] to impact the locomotor activity of males in the open-
field maze. HIV-1 Tg genotype, stress, and sex [F(1,31) =  5.11, 
p =  0.03] also interacted to impact the locomotor activity of 
males (Figure  2C) in the open-field maze. However, post  hoc 
assessment did not attribute these main effects or interactions to 
differences between any two specific groups. All main effects and 
interactions are detailed in Table 4.
Female hiV-1 Tg rats exhibit 
Decreased Performance in novel 
Object recognition Task
The novel object recognition task was performed with no delay 
or 1-h delay from exposure to familiar objects. Stress did not 
impact total time sniffing object in males [F(1,32) = 0.31, p > 0.05] 
or females [F(1,26) = 0.02, p > 0.05]. Time (no delay vs. hour delay) 
[F(1,26) =  1.53, p >  0.05] had no impact on total time sniffing 
objects in females (Figure 3A). Female HIV-1 Tg rats spent less 
time sniffing all objects compared to WT females at each time 
point [F(1,26) = 6.78, p = 0.02] (Figure 2A), and HIV-1 Tg females 
exhibited a reduced difference in time sniffing the novel vs. 
the familiar object compared to female WT rats [F(1,26) =  5.39, 
p = 0.03] (Figure 3B). Male HIV-1 Tg rats spent a reduced total 
time sniffing all objects [F(1,32) = 7.5, p < 0.01] (Figure 3C). Stress, 
genotype, and time interacted [F(1,32) = 5.17, p = 0.03] to impact 
the difference in time spent sniffing the novel vs. familiar object 
in males (Figure 3D). This difference was not attributable to a 
particular group difference.
hiV-1 Tg rats exhibit enhanced 
ramification in hippocampal Microglia
The estimated population of microglia in the hippocampus in 
females was unchanged by stress [F(1,8) = 3.26, p > 0.05] or genotype 
[F(1,8) = 0.32, p > 0.05, Table 5]. Hippocampal microglia in HIV-1 
Tg rats exhibited an increased number of branches [F(1,8) = 14.62, 
p <  0.01], number of junctions [F(1,8) =  13.94, p <  0.01], and 
maximum branch length [F(1,8) =  14.31, p <  0.01], but average 
branch length was unchanged [F(1,8) = 1.45, p > 0.05] compared to 
FigUre 2 | hiV-1 Tg and WT rats were placed in an open-field maze during the rats’ light and dark cycles. The distance traveled and the percentage of 
time the rats spent in the center of the maze were measured. HIV-1 Tg rats traveled a decreased distance compared to WT controls in the light cycle (a). Male (c) 
and female (a) rats traveled an increased distance in the dark cycle compared to the light cycle. The percentage of time rats spent in the center was unaffected by 
stress or transgene in males (D). Female Tg rats spent a decreased percentage of time in the center compared to WT female rats during the light cycle (B). Male (D) 
and female (B) rats spent an increased percentage of the time in the center during the dark cycle. Data are presented as mean ± SEM. & denotes the main effect of 
time. *Denotes a main effect in a t-test collapsed across stress. α = 0.05.
TaBle 4 | F-statistics and p-values for all main effects and interactions are shown for behavior analysis using a three-way anOVa between factors 
(hiV-1 genotype, stress) and within factors (time).
hiV-1  
genotype
stress Time stress × time hiV-1 
genotype × time
stress × hiV-1 
genotype
stress × hiV-1 
genotype × time
Female distance 
traveled (2A)
F(1,36) = 0.78, 
p > 0.05
F(1,36) = 1.78, 
p > 0.05
*F(1,36) = 52.5, 
p < 0.01
F(1,36) = 0.10, 
p > 0.05
*F(1,36) = 8.68, 
p < 0.01
F(1,36) = 0.67, 
p > 0.05
F(1,36) = 0.26, 
p > 0.05
Female percent time in 
center (2B)
F(1,36) = 4.06, 
p > 0.05
F(1,36) = 0.38, 
p > 0.05
*F(1,36) = 29.3, 
p < 0.01
F(1,36) < 0.01, 
p > 0.05
F(1,36) = 0.03, 
p > 0.05
F(1,36) < 0.01, 
p > 0.05
F(1,36) = 0.86, 
p > 0.05
Male distance traveled 
(2C)
F(1,31) = 0.66, 
p > 0.05
F(1,31) = 0.08, 
p > 0.05
*F(1,31) = 56.9, 
p < 0.01
F(1,31) = 1.78, 
p > 0.05
*F(1,31) = 13.2, 
p < 0.01
F(1,31) = 0.87, p > 
0.05
*F(1,31) = 5.11, 
p = 0.03
Male percent time in 
center (2D)
F(1,31) = 0.06, 
p > 0.05
F(1,31) = 1.53, 
p > 0.05
*F(1,31) = 24.5, 
p < 0.01
F(1,31) = 0.72, 
p > 0.05
F(1,31) = 0.03, 
p > 0.05
F(1,31) = 0.01, 
p > 0.05
F(1,31) = 0.42, 
p > 0.05
Female total time 
sniffing objects (3A)
*F(1,26) = 6.78, 
p = 0.02
F(1,26) = 0.02, 
p > 0.05
F(1,26) = 1.53, 
p > 0.05
F(1,26) = 0.06, 
p > 0.05
F(1,26) = 0.61, 
p > 0.05
F(1,26) = 2.07, 
p > 0.05
F(1,26) = 0.13, 
p > 0.05
Female difference in 
sniffing time (3B)
*F(1,26) = 5.39, 
p = 0.03
F(1,26) = 0.90, 
p > 0.05
F(1,26) = 1.25, 
p > 0.05
F(1,26) = 0.82, 
p > 0.05
F(1,26) = 0.45, 
p > 0.05
F(1,26) = 3.28, 
p > 0.05
F(1,26) = 0.45, 
p > 0.05
Male total time sniffing 
objects (3C)
*F(1,32) = 7.50, 
p < 0.01
F(1,32) = 0.31, 
p > 0.05
F(1,32) < 0.01, 
p > 0.05
F(1,32) = 0.05, 
p > 0.05
F(1,32) = 0.45, 
p > 0.05
F(1,32) = 0.02, 
p > 0.05
F(1,32) = 1.04, 
p > 0.05
Male difference in 
sniffing time (3D)
F(1,32) = 0.53, 
p > 0.05
F(1,32) = 0.64, 
p > 0.05
F(1,32) = 0.03, 
p > 0.05
F(1,32) = 1.53, 
p > 0.05
F(1,32) < 0.01, 
p > 0.05
F(1,32) = 0.55, 
p > 0.05
*F(1,32) = 5.17, 
p = 0.03
*Indicates a significant main effect or interaction. The figure or table number is included in parentheses following the description of each metric. α = 0.05.
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FigUre 3 | Total time sniffing novel and familiar objects were measured in the novel object recognition task. This task was performed with no delay or 
1-h delay following exposure to familiar objects. Female HIV-1 Tg rats spent less time sniffing all objects (a). Female Tg rats spent a reduced difference in time 
sniffing the novel vs. familiar object compared to female WT control rats (B). Male HIV-1 Tg rats spent less time sniffing all objects (c), and genotype, stress, and 
time interacted to impact the difference in time spent sniffing the novel vs. familiar object in males (D). Data are presented as mean ± SEM. # denotes a main effect 
of HIV-1 Tg genotype. α = 0.05.
TaBle 5 | The estimated population of iBa-1-stained microglia was 
determined using the optical fractionator probe (stereo investigator).
Mean (estimated  
number of cells)
seM
Wild type No stress 4.28 × 1010 5.29 × 109
Stress 3.95 × 1010 1.91 × 109
HIV-1 transgenic No stress 4.34 × 1010 5.72 × 108
Stress 3.53 × 1010 2.8 × 109
A two-way ANOVA was used to determine the statistical significance. There were 
no significant main effects of stress or HIV-1 genotype nor interactions to impact the 
estimated population of microglia. Mean and SEM are shown. α = 0.05.
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WT rats (Figure 4). An a priori t-test showed that stress increased 
the number of branches (t4 = 4.64, p = 0.01) and number of junc-
tions (t4 = 4.46, p = 0.01) in WT-stressed rats compared to WT 
controls. Representative images and skeletonized microglia are 
shown in Figure 5.
Estimated blood vessel length in WT and HIV-1 Tg rats was 
not significantly different in the PFC (t6 = 0.2436, p = 0.8157), 
hippocampus (t9 = 1.667, p = 0.1298), or amygdala (t9 = 0.2770, 
p = 0.7880). Blood vessel density was also unchanged in the PFC 
(t6 = 1.064, p > 0.05), hippocampus (t9 = 1.007, p > 0.05), and 
amygdala (t9 = 1.044, p > 0.05) (Table 6).
expression of inflammatory Markers is 
increased in Female hiV-1 Tg rats
Gene expression of complement factor B (Cfb) in the hippocam-
pus was higher in female HIV-1 Tg rats compared to WT rats 
(t19 = 2.87, p = 0.01) (Figure 6B). Gene expression of lipocalin-2 
(Lcn2) was unchanged in the hippocampus (t15 = 1.18, p > 0.05) 
but decreased in the PFC (t15 = 2.40, p = 0.03) in female HIV-1 
Tg rats compared to WT controls (Figure 6A). Statistical analysis 
information is detailed in Table 7.
DiscUssiOn
Collectively, the data presented here demonstrate that develop-
ment in the presence of HIV-1 proteins leads to anxiety-like 
FigUre 4 | Morphology of iBa-1-stained microglia was assessed using the analyzeskeleton function in imageJ. Microglia in female HIV-1 transgenic 
rats exhibited enhanced ramification characterized by an increased number of branches (a), junctions (B), and maximum branch length (c). Stress did not impact 
microglial morphology, and the average branch length was unchanged in any group (D). Data are presented as mean ± SEM. *Denotes a main effect of HIV-1 
transgene. # denotes significant effect of stress in an a priori t-test. α = 0.05.
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behavior and ramification of microglia. The combination of 
chronic adolescent stress with HIV-1 protein expression did not 
further exacerbate the impact of HIV-1 proteins in females. While 
the presence of HIV-1 proteins can alter male body morphology 
and behavior, the impact on these metrics appears to be more 
salient in adolescent females.
Although HIV-1 Tg female rats exhibited normal locomo-
tor behavior during the dark cycle, during the more anxiety-
provoking light cycle, female HIV-1 Tg rats exhibited decreased 
locomotor activity in the open field and reduced central tendency 
as compared to WT females. This context-specific change in loco-
motor activity suggests that the alterations in distance traveled 
are not due to a physical impairment. This is consistent with a 
previous study in adolescent female HIV-1 Tg rats in which a 
trend toward decreased time in the center of an open-field maze 
was observed (15). All rats, regardless of genotype, sex, or stress, 
showed reduced central tendency in the light cycle compared to 
the dark cycle, suggesting that all rats responded to the anxiety-
provoking stimulus of bright light.
Unlike previous reports from our group that demonstrated 
an increase in anxiety-like behavior in female rats following 
chronic adolescent stress (21, 22, 28), the current study did not 
find a main effect of stress on central tendency in the open field. 
This may be a reflection of strain-specific sensitivities to chronic 
adolescent stress, as the previous reports from our group were 
conducted in Wistar or Sprague–Dawley rats (21, 22, 28), and 
the current study was conducted in Fisher rats as these are the 
background strain of the HIV-1 Tg rat. While the timing of the 
adolescent stress paradigm was consistent with previous studies 
from our group that documented behavioral effects of chronic 
adolescent stress (21), it is possible that, had the adolescent 
stress paradigm continued throughout the behavioral testing 
days, the behavioral effects could have been more robust. And 
while the adolescent stress paradigm takes place during the 
average age of pubertal onset, timing that may be particularly 
disruptive to female behavior, no behavioral effects of adolescent 
stress were observed in females or males. However, both chronic 
adolescent stress and the presence of HIV-1 viral proteins 
reduced adolescent weight gain (PND36–46). The fact that 
chronic stress was able to alter physiological endpoints suggests 
that although Fisher rats may not be as behaviorally sensitive to 
chronic adolescent stress as Wistar and Sprague–Dawley rats, 
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FigUre 5 | hiV-1 transgenic and wild-type rats were exposed to chronic adolescent stress or left non-stressed during adolescence. Brains were 
sectioned at 40 μm and stained for IBA-1 and visualized with diaminobenzidine. Representative images of the hippocampus for HIV-1 Tg, WT, stressed, and 
non-stressed rats are shown (a). Images were adjusted for brightness and contrast. Scale bar = 50 μm. IBA-1-stained microglia were then converted to 8-bit, 
adjusted for brightness, and cleaned with a Gaussian filter. Images were converted to binary and skeletonized in ImageJ. Representative images of non-stressed 
WT, stressed WT, non-stressed Tg, and stressed Tg rats are shown (B).
TaBle 6 | Blood vessel length and density were estimated using the spaceballs probe (stereo investigator).
region Measure genotype n Mean ± seM T statistic p-value
Hippocampus Length (μm) WT 5 5.653 × 106 ± 439454 t9 = 1.667 0.1298
Tg 6 4.743 × 106 ± 339171
Density (μm/μm3) WT 5 2.025 ± 0.2465 t9 = 1.007 0.3401
Tg 6 1.774 ± 0.1019
PFC Length (μm) WT 3 4.380 × 106 ± 920262 t6 = 0.2436 0.8157
Tg 5 4.633 × 106 ± 595337
Density (μm/μm3) WT 3 2.551 ± 0.08156 t6 = 1.064 0.3281
Tg 5 3.164 ± 0.4294
Amygdala Length (μm) WT 5 3.591 × 106 ± 189420 t9 = 0.2770 0.788
Tg 6 3.700 × 106 ± 320519
Density (μm/μm3) WT 5 1.280 ± 0.07705 t9 = 1.044 0.3237
Tg 6 1.402 ± 0.08481
A student’s t-test was used to compare vessel length and density between WT and HIV-1 Tg rats in the hippocampus, PFC, and amygdala. Mean, SEM, and test statistics are 
shown. HIV-1 Tg rats did not exhibit significantly different blood vessel length or density in any region. α = 0.05.
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chronic adolescent stress is a salient environmental stimuli in 
the Fisher strain.
The novel object recognition task was performed to assess 
object recognition memory. The test was performed with either 
no delay or 1-h delay following exposure to the familiar objects. 
The no-delay condition serves as a control for confounds of 
differences in investigative behavior that could be driven by an 
underlying difference in anxiety-like behavior. A non-zero differ-
ence in novel vs. familiar object investigation may be interpreted 
as lack of memory impairment; that is, the animal differentiates 
between the two objects and displays a preference for one. Both 
female and male HIV-1 Tg rats spent a decreased amount of time 
sniffing all objects in the no-delay paradigm as compared to WT 
controls. Female HIV-1 Tg rats displayed a reduction in inves-
tigation of novel and familiar objects compared to WT females. 
Though this reduction is present in both the no delay and 1-h 
delay conditions, rats persisted in displaying a difference in time 
spent exploring the novel vs. familiar objects, suggesting object 
recognition despite reduced overall exploration. Although a 
cognitive deficit cannot be completely ruled out, the combination 
of reduced investigative behavior and no difference between no-
delay and hour-delay conditions suggests that these animals do 
not suffer from overt memory impairments, but rather a decrease 
in investigation. The current testing is not designed to determine 
if this decreased investigation is a reflection of decreased motiva-
tion or increased anxiety-like behavior; however, an interpreta-
tion of increased anxiety-like behavior is consistent with the 
anxiety-like behavior observed in the open-field test. Previous 
studies have reported mixed results regarding memory impair-
ment in HIV-1 Tg rats. In the Morris Water Maze, HIV-1 Tg rats 
exhibited decreased learning but no change in memory of the 
hidden platform (29). Conversely, a study by Repunte-Canonigo 
et  al. observed impaired working memory in the T-maze (16). 
Here, we had hypothesized that stress and HIV-1 proteins would 
interact to impair memory, but these data suggest that neither 
condition alone nor the combined impact of these factors is suf-
ficient to cause memory impairment in adolescent rats.
In order to collect tissue at the same age and without the stress 
of estrous cycle tracking, samples from female rats could not be 
collected at every stage of the estrous cycle. Both the behavioral 
metrics (PND49–53) and the weight data were collected across 
multiple days and therefore could not be tied to any one stage of 
the estrous cycle. As we have reported previously (21, 22, 28), we 
collected uterine weights at the completion of the study to deter-
mine whether systematic group differences in estrous cycle might 
be present. Figure  1D demonstrates that uterine weights were 
not systematically different among groups, and therefore, there 
likely was not a group difference in estrous cycle stage. These data 
confirm that reported differences in behavior and inflammatory 
endpoints are likely not caused by different estrous cycle stages 
FigUre 6 | Quantitative real-time Pcr was performed to assess gene 
expression of complement factor B and lipocalin-2. Lcn2 expression 
was decreased in the prefrontal cortex but not hippocampus of HIV-1 Tg rats 
(a). Cfb gene expression was increased in the hippocampus of HIV-1 Tg rats 
(B). Data are presented as mean ± SEM. *Denotes a main effect of HIV-1 
transgene. α = 0.05.
TaBle 7 | F-statistics and p-values for all main effects and interactions 
are shown for microglia and gene expression analysis.
hiV-1 genotype stress stress ×  
hiV-1 genotype
Microglial branches 
(4A)
*F(1,8) = 14.62, 
p < 0.01
F(1,8) = 2.17, 
p > 0.05
F(1,8) = 2.38, 
p > 0.05
Microglial junctions 
(4B)
*F(1,8) = 13.94, 
p < 0.01
F(1,8) = 2.98, 
p > 0.05
F(1,8) = 2.59, 
p > 0.05
Microglial max 
branch length (4C)
*F(1,8) = 14.31, 
p < 0.01
F(1,8) = 0.29, 
p > 0.05
F(1,8) = 0.02, 
p > 0.05
Average branch 
length (4D)
F(1,8) = 1.45, 
 p > 0.05
F(1,8) = 0.97, 
p > 0.05
F(1,8) = 1.32, 
p > 0.05
Lcn2 hippocampus 
(4A)
t15 = 1.18,  
p > 0.05
Lcn2 PFC (4A) *t15 = 2.40, p = 0.03
Cfb (4B) *t19 = 2.87, p = 0.01
IBA-1-estimated 
population 
(Table 5)
F(1,8) = 0.32, p > 0.05 F(1,8) = 3.26, 
p > 0.05
F(1,8) = 0.54, 
p > 0.05
A two-way ANOVA was used for microglial morphology analysis (between-factors 
HIV-1 genotype and stress). A student’s t-test was used to assess significance of gene 
expression data.*Indicates a significant main effect or interaction. Blank boxes indicate 
an absence of a particular factor from analysis. The figure or table number is included 
in parentheses following the description of each metric. α = 0.05.
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among groups; however, variations in estrous cycle stage may 
contribute to variability within groups, though a previous report 
suggests that differences in estrous cycle do not increase group 
variability over what is observed in males (30).
Our current findings of anxiety-like behavioral alterations in 
females are consistent with our previous demonstration of altered 
affective-like behavior and stress responses in female HIV-1 Tg 
rats (15, 31). In order to elucidate the mechanisms potentially 
underlying these behavioral changes, we evaluated microglial and 
vascular morphology in female HIV-1 Tg rats. The hippocampus 
has been previously investigated in HIV-1 Tg rats due to its estab-
lished susceptibility to neuroinflammation and damage by HIV-1 
viral protein exposure (32, 33), and we have previously reported 
HIV-1 induced deficits in hippocampal neurogenesis (15). In the 
present study, we first examined whether microglial activation, 
indicative of neuroinflammation, was altered with stress or in 
female HIV-1 Tg rats. The estimated population of IBA-1 posi-
tive microglia was unchanged with stress or exposure to HIV-1 
transgene. While we did not observe differences in the number 
of IBA-1 positive microglia, a previous study found increased 
gene expression of Iba-1 in adult HIV-1 Tg rats, though they did 
not specify the sex of the animals tested (16). Thus, there may be 
potential sex- or age-dependent variations in microglial profiles 
in the HIV-1 Tg rats.
For more in-depth assessment of microglia, we examined 
microglial morphology and branching. Microglia in HIV-1 Tg 
female rats exhibited a hyper-ramified structure, characterized by 
increased number of junctions and branches. Hyper-ramification 
has been hypothesized to be an intermediate stage in microglial 
activation (34), and hyper-ramified microglia have been associ-
ated with impaired working memory following stress (35); how-
ever, detailed behavioral consequences of enhanced microglial 
ramification are not well established (35). The enhanced micro-
glial ramification observed in the hippocampus of the adolescent 
female HIV-1 Tg rats is likely a consequence of the presence of 
HIV-1 viral proteins because this morphology is present even in 
the absence of chronic stress exposure. However, it is premature 
to conclude that these changes in microglial morphology are 
behaviorally salient in this particular case. We observed similar 
ramification following chronic adolescent stress in female adoles-
cent WT rats that did not co-occur with behavioral alterations. 
Collectively, these data suggest that both development with 
HIV-1 proteins and chronic adolescent stress are independently 
capable of inducing ramified microglia in the female adolescent 
hippocampus, but these two stimuli do not appear to interact at 
the level of microglial ramification.
In addition to microglial morphology, we assessed vasculari-
zation of the hippocampus based on previous demonstrations of 
altered vascularization following stress (36). There was no effect of 
HIV-1 on vascularization of the hippocampus (Table 1). Because 
of previous reports of alterations in the PFC of HIV-1 Tg rats (31) 
and the potential for stress to impact vascularization in other brain 
regions (36), we also assessed vascular endpoints in the PFC and 
amygdala. Similar to the hippocampus, vascularization of neither 
the PFC nor the amygdala was impacted by development in the 
presence of HIV-1 proteins. When these vascularization data 
are viewed in light of the alterations in microglial morphology 
reported above as well as previously published demonstration of 
reduced neurogenesis (15), they suggest that glial and neuronal 
alterations are not secondary to a primary change in vascular 
structure.
In order to determine if the inflammatory profile suggested by 
microglial ramification extended to other metrics, we assessed 
the expression of two inflammatory markers linked to HIV-1. 
We have previously reported that Mcp-1 expression is elevated 
in the hippocampus of HIV-1 Tg female rats, but assessments 
of other portions of the innate immune system have not been 
reported (15). We assessed expression of complement factor 
B, a component of the alternative complement pathway in the 
innate immune system. Activity in the complement cascade in 
individuals with HIV-1 has previously been studied in context 
of HIV-associated cognitive impairments; previous studies 
found elevated protein expression of complement component 3 
(C3) in patients diagnosed with HIV-associated dementia (37). 
Complement activation has also been investigated as a mecha-
nism of neurodegeneration in patients with HIV-1 (38) as well as 
in other central nervous system disorders (39). As demonstrated 
in Figure 6, expression of Cfb was increased in the presence of 
HIV-1 proteins in adolescent female rats. An increase in activation 
of both the alternate and classical complement pathway in HIV 
patients has been reported (40), and it has been hypothesized that 
factor B is protective against HIV-1 infection (41). Interestingly, 
here, we saw increased complement factor B in the absence of a 
true infection as only the viral proteins are expressed, suggesting 
that the proteins themselves are an inflammatory stimulus.
The complement system has effects on neuronal architecture 
beyond the commonly appreciated inflammatory effects of this 
system (42), and these non-traditional impacts of innate immune 
system activation could contribute to impairments observed in 
PLWH. With this in mind, we also examined gene expression of 
lipocalin-2 (Lcn2), an acute phase protein that plays an important 
role in dendritic spine remodeling and anxiety-like behavior 
(43, 44), as dendritic damage has been cited as a contributor 
to development of HAND (45, 46). Although Lcn2 expression 
was unaltered in the hippocampus, it was reduced in the PFC of 
HIV-1 Tg female rats. Region-specific alterations in gene expres-
sion have been reported previously in the HIV-1 Tg rat (31, 47). 
Further investigating inflammatory markers for their potential to 
effect stress- and HIV-1-induced changes in structural plasticity 
may help elucidate the mechanisms underlying the behavioral 
changes reported here.
Collectively, the current findings suggest that HIV-1 proteins 
are a potent physiologic and behavioral modifier. These findings 
reinforce the hypothesis that the biological impacts of HIV-1 
viral protein exposure, rather than the psychosocial impacts of 
diagnosis and disease management, may be responsible for HIV-
1-associated behavioral alterations. The use of a stress-based 
animal model provided the tools necessary to isolate the impact 
of psychosocial variables from biological influences of HIV-1 to 
gain insight into the mechanisms potentially underlying psychi-
atric and cognitive dysfunction in PLWH. Future studies should 
further elucidate specific mechanisms involved in HIV-1-related 
behavioral changes. The data presented here, in combination 
with previous reports (15), suggest that HIV-1 proteins disrupt 
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behavior and lead to neuroinflammatory effects. However, the 
behavioral and neuroinflammatory effects are not directly linked, 
at least not by traditional mechanisms. Although HIV-1 is an 
immune disorder and has profound inflammatory implications, 
other systems may be more directly influential in behavioral 
alterations, such as the hypothalamic–pituitary–adrenal axis (31), 
neuronal morphology (42), or dopaminergic systems (13, 14).
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